Rosetta Genomics

Rosetta Genomics

Discovering, developing, and commercializing next generation diagnostic tests for personalized medicine.

Launch date
Employees
Market cap
AUD45.8k
Enterprise valuation
AUD46k (Public information from Sep 2024)
Princeton New Jersey (HQ), Rehovot Center District (founding location)
  • Edit
DateInvestorsAmountRound
N/A

N/A

IPO
N/A

$2.5m

Post IPO Equity
N/A

$2.7m

Post IPO Equity
N/A

$1.5m

Post IPO Equity
N/A

$1.8m

Post IPO Equity

$10.0m

Valuation: $10.0m

Acquisition
Total Funding-

Recent News about Rosetta Genomics

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.